Type(s) of Cancer
Breast
Breast
Study Phase
Phase 3
Study Completion Date
May 2007
May 2007
NCT00089661Uploaded 09-26-2016
Available for Download
PDS UID: Breast_Amgen_2004_153
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Files:
PROTOCOL20040135 Protocol Amend 3 REDACTED.pdf
CRFAmgen 20040135 CRF REDACTED.pdf
DATA DICTIONARYAmgen 20040135 DDT.pdf
DATA (COMPARATOR ARM)Amgen 20040135 SAS datasets.zip